They say a picture is worth a thousand words, and the online news site Vox recently sought to open Americans’ eyes as to how much more we pay for healthcare compared to other countries.
America’s healthcare prices are out of control. These 11 charts prove it.
I can’t copy their charts, but basically they are bar graphs. The bar that shows how much patients in the US pay for similar drugs and services towers over the others like a skyscraper over a neighborhood of single-family homes. Like this:
Vox got its information from the International Federation of Health Plans (IFHP)… Continue reading
EpiPens – lifesaving but costly
I’m allergic to bee stings, so I keep an EpiPen handy when I’m working out in my garden this time of year.
But my EpiPens are more than 3 years old now, and it’s time to invest in a new set.
Why do I say invest? Because EpiPens are incredibly expensive!
Related post: First aid for bee stings
I didn’t know that three years ago when I bought them. At that time, my health insurance did not include coverage for prescription medications (all ACA-compliant plans must now), so I paid the full price out of … Continue reading
Up, up and away!
Does anyone’s income go up as fast as their health insurance premium? I wish.
11.6%. That’s how much more my current health insurance provider wants to charge for my bronze high-deductible health plan in 2017.
And although 11.6% seems like a lot to me, another company in my state is requesting a 19.9% average increase on all its plans, with a 28% increase on its gold plan!
So far, the rate increases that have been made public in other states are all pretty high, averaging well into the double digits. So at least I’m not … Continue reading
Time is money
Maybe you have affordable health insurance and a doctor you like.
But have you ever had the experience of calling for an appointment for a sore throat, a bladder infection, back pain, or some other minor ailment and being told that the doctor’s next available appointment is in six weeks?
Or you get a same-day appointment, but then have to take time off work, drive to the clinic, perhaps pay for parking, and then wait to be seen by the doctor. For a five-minute appointment.
It’s frustrating, sure, but it’s also costly when you consider the time … Continue reading
I just read about health insurance giant UnitedHealth’s bold but risky new insurance plan, Harken Health:
UnitedHealthcare is betting $65 million that it can profit by making primary care more attractive.
With little fanfare, the nation’s largest health insurer launched an independent subsidiary in January that offers unlimited free doctor visits and 24/7 access by phone. Every member gets a personal health coach to nudge them toward their goals, such as losing weight or exercising more. Mental health counseling is also provided, as are yoga, cooking and acupuncture classes.
At this time, Harken Health is only available in Chicago … Continue reading
I just read about another case where a pharmaceutical company bought the rights to an old, been-around-forever drug and then drastically increased the price. Argh.
A few months ago I posted about the drug Daraprim, which was bought by Turing Pharmaceuticals. Its CEO, the now infamous Martin Shkreli, raised the price from $13 a pill to over $700.
Last February, Valeant Pharmaceuticals bought the rights to Seconal (secobarbital), an 80-year-old sleeping pill. Ten years ago 90 Seconal tablets cost about 30 dollars. Now it’s closer to $3,000.
It’s believed Valeant did this in response to California’s new End … Continue reading
Just yesterday I posted about the United States Preventive Services Task Force (USPSTF) and the fine line they walk between providing evidence-based recommendations for screening tests and making medical specialist groups happy.
Sometimes it just doesn’t happen.
The task force recently gave an “I” grade to vision screening in patients over 65. An I grade, or Insufficient evidence, means that the task force can’t definitively say that the benefits of vision screening in older adults outweigh the possible harms.
The American Academy of Ophthalmology (AAO) doesn’t agree.
Specifically, the task force reviewed the evidence for primary care doctors screening for … Continue reading
One of the driving forces behind rising health care costs is the increasingly high cost of prescription drugs.
And because 60% of Americans take at least one prescription drug, that adds up to a lot of money.
Insurance companies are trying to rein in costs by having tiered copayments (higher for brand names) or limiting the selection of drugs on their formularies (the list of drugs your insurance will cover).
This post gives you some suggestions to save money, and some resources that might be helpful.
But first, ask yourself and your physician if a prescription drug is really … Continue reading
Last November, with much media coverage, several members of Congress announced the formation of The Affordable Drug Pricing Task Force, promising to “take action to combat the skyrocketing costs of pharmaceuticals.”
Finally! I thought.
Related post: Prices continue to increase for generics
But I haven’t heard much since then.
There was a little noise earlier this month when the House Oversight Committee (of which the task force is a subcommittee, I believe) attempted to grill the now infamous Martin Shkreli about why he thought it was okay to jack up the price of Daraprim from $13 a pill to … Continue reading
The Advisory Committee for Immunization Practices (ACIP) and the Centers for Disease Control (CDC) have just released an updated vaccination schedule for adults.
I’ve included the schedule and accompanying information from the CDC’s website at the end of this post.
You can also print it out to take to your primary care provider.
Related post: Adults need vaccinations, too!
It’s color coded to make it easier to follow the recommendations, and I think it’s an improvement over last year’s chart.
A yellow row/column means the vaccine is recommended for everybody in that age group; purple indicates the vaccine is for … Continue reading